PharmaCorp Rx Inc. (TSXV:PCRX)
Canada
· Delayed Price · Currency is CAD 0.4600
0.00 (0.00%)
May 30, 2025, 4:00 PM EDT
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 53.04 million as of May 30, 2025.
Market Cap
53.04M
Enterprise Value
41.25M
Revenue
9.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 53.04M, an increase of 2,109.83%. That is a compound annual growth rate of 219.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 53.04M | -16.24% |
| Dec 31, 2024 | 63.32M | 427.65% |
| Dec 30, 2022 | 12.00M | 400.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royal Bank of Canada | 252.28B |
| Brookfield Asset Management | 219.78B |
| The Toronto-Dominion Bank | 162.46B |
| Enbridge | 137.51B |
| Brookfield | 123.30B |
| Thomson Reuters | 122.51B |
| Bank of Montreal | 107.02B |
| Canadian Pacific Kansas City | 103.99B |